Zoloft may cause birth defects when a woman takes it during pregnancy. If you or a loved one has given birth to a child with a birth defect and the mother took Zoloft during pregnancy, you may be entitled to financial compensation.
Zoloft is prescribed for many purposes. Sertraline is used to treat depression, obsessive-compulsive disorder (bothersome thoughts that won’t go away and the need to perform certain actions over and over), panic attacks (sudden, unexpected attacks of extreme fear and worry about these attacks), posttraumatic stress disorder and others. Regardless of the reason of prescription, women who take this drug may experience a greater than average risk of infant child birth defects, including but not limited to heart defects, cleft palate, cleft lip, skeletal deformations and more. If your child experienced such a horrific side effect, please call our team of Zoloft lawyers today for a free case evaluation on how we can help.
How Do Pregnant Women React to Zoloft?
Zoloft medication is prescribed so that it alters the biochemical balance in the brain. Desirable effects that are aimed by this alteration include
- Reduce depression
- Reduce the occurrence of panic attack
- Decrease the effects of PTSD (post traumatic stress disorder)
- Treat obsessive-compulsive disorder (OCD)
- Treat sexual function impairment in men
- Reduce anxiety
- Reduce social anxiety
- Treat symptoms of IBS (irritable bowel syndrome)
However, these benefits may be offset by the side effects that accompany usage of this medication. The undesirable effects are observed in all ages and gender. To begin with, children may experience symptoms such as fever, temporary loss of control of the bladder, soreness or even infection of the sinus and hyperactivity. They may also experience a frequently bloody nose. The skin of the child might also develop bruise-like marks. These symptoms will go away when the child stops taking the medication.
Men who take the drug may also experience side effects. These are mostly related with the way the male hormones are affected by Zoloft. Reduced libido and sexual dysfunction are common undesirable effects. Anorexia, constipation and sleeplessness are also possible. Just like in children, these symptoms rapidly decrease and disappear when the medication is stopped.
In women, Zoloft alters the level of female hormones. Side effects that result due to this alteration include breast softness, mood swings, weight gain/loss, cramping, sleeplessness and a general feeling of weakness. These effects are more severe in pregnant women due to the hormone alterations already caused by pregnancy. The symptoms also seem to last longer in women than in men and children. This is because it takes longer for the hormone balance to be restored in women.
Women who take Zoloft while pregnant may also put their unborn babies at risk. The medication has been linked to cause birth defects in children. These defects include heart defects, miscarriages, premature birth, and delay in development, persistence pulmonary hypertension, skull /cranial defects, and abdominal defects among others.
The Problem
Our firm is offering free nationwide case evaluations to families whose children were diagnosed with medical conditions at birth or shortly therafter when the mother ingested Zoloft during pregnancy. Specific birth defects include cardiac malformations (ASD, VSD, Left Hypoplastic Heart Syndrome, coarctation of the aorta, Tricuspid or Pulmonary Atresia, Pulmonary Stenosis, transposition of the great vessels or any other heart defect), neural tube defect, craniosynostosis, cleft lip, cleft palate, skeletal deformations, and club foot.
About Zoloft
Our team of attorneys are currently reviewing potential Zoloft® lawsuits involving women who took these drugs during early pregnancy and whose children suffered adverse side effects, including heart defects and cleft lip/palate, among with others.
Manufactured by Pfizer, Inc., Zoloft® is generically known as sertraline hydrochloride and is a drug prescribed to treat major depression in adults, as well as obsessive-compulsive disorder, panic and social anxiety disorders and post-traumatic stress disorder in both adults and children. Zoloft is classified as a selective serotonin reuptake inhibitor (SSRI) drug, meaning that it selectively affects serotonin. Serotonin is one of many chemicals in the brain called neurotransmitters, which pass messages between nerve cells, and has been linked in various studiesto an increased risk of birth defects.
The Food and Drug Administration (FDA) initially placed SSRI antidepressants, including Zoloft, in its pregnancy Category C. This pregnancy category means that animal reproduction studies have shown an adverse effect on the fetus, but there have not yet been adequate and well-controlled studies in humans. Pregnancy categories measure the teratogenic effects a drug has on a fetus. Teratogenic means that a drug or other substance is capable of interfering with the development of a fetus, so there could be serious risks to the unborn baby of a woman taking Zoloft while pregnant.
Birth defects or conditions that may be associated with the use of Zoloft include:
- Abdominal wall defects (infant omphalocele)
- Anal atresia (complete or partial closure of the anus)
- Cleft lip and cleft palate
- Clubfoot (one or both feet turn downward and inward)
- Heart (cardiac) defects
- Skull defect (craniosynostosis)
Zoloft was approved by the FDA and introduced into the market in 1991. Prior to 2002, the drug was approved only for use in adults ages 18 and over. In 2002, the FDA approved Zoloft to treat severe obsessive compulsive disorder in children ages six and older.
The FDA issued a Public Health Advisory on Dec. 8, 2005, warning that use of certain antidepressants during the first trimester of pregnancy may be associated with an increased risk of birth defects. The advisory was based on U.S. and Swedish studies showing that exposure to certain antidepressants increased the risk of heart defects, including atrial and ventrical septal defects, conditions in which the wall between the right and left sides of the heart is not completely developed.
Citing a study by Christina Chambers of the University of California, San Diego, that was published in the New England Journal of Medicine, Health Canada issued a strong warning in March 2006 to pregnant women or women who were trying to become pregnant that antidepressant drugs like Zoloft could potentially pose serious risks to unborn or even nursing babies.
A 2007 study published in the New England Journal of Medicine found a “significant association” between Zoloft and septal defects. A septal defect is a congenital defect that affects the structures of the heart. Septal defects can lead to the improper circulation of blood, making the heart work overtime. An atrial septal defect (ASD) is a hole in the wall between the heart’s two upper chambers. A hole in the wall between the two lower chambers is called a ventricular septal defect (VSD). Septal defects can be life threatening. According to the study, mothers who take Zoloft during pregnancy may double the risk of having an baby born with septal defects.
In another study published in the March 2010 issue of Pediatrics, researchers found a potential association between exposure to antidepressants in late pregnancy and a delay in normal motor development skills at six and 19 months of age. The same researchers, in a 2009 study published by British Medical Journal, found that women who were pregnant and taking certain antidepressants during the first trimester had an increased risk of giving birth to babies having various heart defects.
A recent study conducted by scientists at the University of Montreal and published online on May 31, 2010, in the Canadian Medical Association Journal suggests that women who take antidepressants like Zoloft during the first trimester of pregnancy are significantly more likely to suffer a miscarriage than women who do not take antidepressants.
The Archive of General Psychiatry published a report in July of 2011 linking SSRI antidepressants such as Zoloft to a potentially increased risk of autism spectrum disorders (ASDs) in babies born to mothers who took these drugs during the first trimester of pregnancy. Performed by researchers at the Kaiser Permanente Medical Care Program in Northern California, the population-based, case-control study compared a group of 298 children having varying degrees of autism and their mothers to another group of 1,507 randomly selected children and their mothers. Nearly 70 children from each group were exposed to antidepressants in the same class as Zoloft, and the researchers found a possible connection between mothers who took these drugs within a year before delivery and an increased the risk of their babies being born with ASDs. The highest risk was found to be among those whose mothers took these drugs during the first trimester.
For a Free Case Evaluation:
TOLL FREE: 1-800-632-1404
EMAIL: click here
FILL OUT THIS FORM:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.